Punjab, Sindh to begin trials for ‘Plasma Therapy’ for COVID-19 patients. What is it?
Pakistan’s top hematologist Dr. Tahir Shamsi said that they are devising a strategy to administer it.
As the tally for Pakistan increases, Punjab and Sindh give a green signal to begin trials for passive immunization to treat the patients of COVID-19. Years-old therapy would be used to treat critically ill patients.
Pakistan’s top hematologist Dr. Tahir Shamsi said that they are devising a strategy to administer it. Following the plasma therapy technique, the plasma of recovered patients will be used to treat patients.
What is plasma therapy?
Patients who have recovered from the disease have permanent antibodies generated by the immune system floating in their blood plasma, the liquid component of blood. To turn that into a cure, the plasma is collected, tested for safety, and purified.
When injected into a critical patient, the “plasma-derived therapy,” also known as convalescent plasma, provides “passive immunity” until the critical patient’s immune system can generate its own antibodies.
The head of the WHO’s emergency program, Mike Ryan, has said that “the convalescent plasma is a ‘significant area to pursue’ as a potential treatment for patients with the coronavirus.”
Can it help Pakistan?
Medical experts in Pakistan have also suggested the use of the convalescent plasma method to the government. The Dean of the National Institute of Blood Diseases in Karachi, Dr. Tahir Shamsi, recently came up with the proposal.
Shamsi said, “Doctors in China have used the method on corona patients and have had very positive results, which they have published for doctors around the world.”
Dr. Tahir Shamsi further said, “A model has been submitted to the government regarding the treatment and its use. The government has agreed to use the method.”
What are your views on this? Share in the comments bar below.